Background: Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark. Objective: This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives. Methods: A qualitative study based on interviews with women who gave birth using remifentanil and the midwives involved in their care.
Background:Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark. Objective:This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives. Methods: A qualitative study based on semi-structured interviews with women who gave birth using remifentanil and the midwives involved in their care. The analysis will be a thematic content analysis. All Danish or English speaking labouring women and midwifes at North Zealand hospital giving birth/attending birth with remifentanil for labour pain are eligible to be included during the study period. After written consent the interview will be conducted 4-10 days after the birth.
Study Type
OBSERVATIONAL
Enrollment
40
University Hospital of Copenhagen, North Zealand Hospital
Hillerød, Select State, Denmark
RECRUITINGDepartment of Anaesthesia and Intensive care, University Hospital of Southern Denmark, Kolding, Denmark
Kolding, Denmark
ACTIVE_NOT_RECRUITINGPræhospital center
Næstved, Denmark
ACTIVE_NOT_RECRUITINGExperiential understanding of remifentanil-assisted labor from the perspectives of mothers
The co-primary outcome is the in-depth qualitative description of how women experience the use of remifentanil for labor pain relief. The outcome will be derived through thematic analysis of semi-structured interview data, aiming to identify key themes related to pain relief, side-effects, safety, communication, autonomy, and overall birth experience. No quantitative scale will be used.
Time frame: Interviews conducted within 4-10 days postpartum
Experiential understanding of remifentanil-assisted labor from the perspectives of midwives
Description: The co-primary outcome is the in-depth qualitative description of how midwifes experience the use of remifentanil for labor pain relief. The outcome will be derived through thematic analysis of semi-structured interview data, aiming to identify key themes related to pain relief, side-effects, safety, communication, autonomy, and overall birth experience. No quantitative scale will be used.
Time frame: Time Frame: Interviews conducted within 4-10 days postpartum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.